Efficacy and Safety of Pegylated Interferon Alfa in Polycythemia Vera
Status:
Completed
Trial end date:
2008-01-01
Target enrollment:
Participant gender:
Summary
Interferon alfa is an effective treatment of polycythemia vera (PV), but about 20% of
patients discontinue their treatment because of side effects and treatment schedule (three
times per week administration). The pegylated form of interferon alfa-2a has shown a better
tolerance in hepatitis patients and is administered only once a week. The purpose of this
study is to determine efficacy and safety of pegylated interferon alfa-2a in the treatment of
PV patients.